The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Vaccines and Related Biological Products Advisory Committee (the Committee). The general function of the Committee is to provide advice and recommendations to FDA on regulatory issues. The meeting will be open to the public. FDA is establishing a docket for public comment on this document.
US Federal Register - FDA Notices · September 09, 2026
Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments—2027 Southern Hemisphere Influenza Virus Vaccines
Original title: Vaccines and Related Biological Products Advisory Committee; Notice of Meeting; Establishment of a Public Docket; Request for Comments-2027 Southern Hemisphere Influenza Virus Vaccines
FDA announces a public advisory committee meeting and opens a docket for comments on 2027 Southern Hemisphere influenza virus vaccines.
Published by US Federal Register - FDA Notices. HealthSignal links to the original document; the summary above is extracted from the source text.